DOV vs FULC · P/E 27, rev $4.24B vs $427.0M cap
Dover Corporation (DOV) versus Fulcrum Therapeutics Inc (FULC) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported FULC revenue for 2025-09-30 was $0. Net income was -$54.5M. FULC currently screens at market cap $427.0M.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. FULC currently screens at market cap $427.0M.
Not investment advice. Open the DOV and FULC stock pages for the full models.
Not investment advice.